The Discounted Cash Flow (DCF) valuation of ChromoGenics AB (CHRO.ST) is (2,418.75) SEK. With the latest stock price at 9.78 SEK, the upside of ChromoGenics AB based on DCF is -24831.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.3% - 5.3% | 4.8% |
| Long-term Growth Rate | 3.0% - 4.1% | 3.5% |
| Fair Price | (12,215.06) - (1,361.09) | (2,418.75) |
| Upside | -124998.4% - -14017.1% | -24831.6% |